X4 PHARMACEUTICALS, INC.

Company

X4 Pharmaceuticals, Inc

Filed

January 13, 2023

Accession Number

0000902664-23-000237

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →